September 08, 2015 |
The St. Louis company has pulled up roots and moved to San Francisco to join the Y Combinator tech accelerator, on a hunch that catching circular RNA could make for a multi-purpose diagnostic further upstream than traditional protein- and antibody-based tests.
WIRED